Standard BioTools Inc.LABNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P85
Within normal range
vs 2Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.50% |
| Q3 2025 | -6.38% |
| Q2 2025 | -7.17% |
| Q1 2025 | -4.57% |
| Q4 2024 | -4.37% |
| Q3 2024 | -3.90% |
| Q2 2024 | -30.18% |
| Q1 2024 | -4.11% |
| Q4 2023 | 223.00% |
| Q3 2023 | -15.46% |
| Q2 2023 | -17.32% |
| Q1 2023 | -19.79% |
| Q4 2022 | -28.96% |
| Q3 2022 | -65.25% |
| Q2 2022 | -267.66% |
| Q1 2022 | -76.74% |
| Q4 2021 | -5.21% |
| Q3 2021 | -10.25% |
| Q2 2021 | -11.85% |
| Q1 2021 | -12.10% |
| Q4 2020 | -10.71% |
| Q3 2020 | 12.03% |
| Q2 2020 | -6.81% |
| Q1 2020 | -8.87% |
| Q4 2019 | -5.85% |
| Q3 2019 | -6.23% |
| Q2 2019 | -19.99% |
| Q1 2019 | 79.50% |
| Q4 2018 | 204.29% |
| Q3 2018 | -36.04% |
| Q2 2018 | -28.56% |
| Q1 2018 | 56.41% |
| Q4 2017 | -29.40% |
| Q3 2017 | 38.77% |
| Q2 2017 | -38.05% |
| Q1 2017 | -27.89% |
| Q4 2016 | -21.90% |
| Q3 2016 | -19.68% |
| Q2 2016 | -15.10% |
| Q1 2016 | -14.01% |